Acadia Pharmaceuticals (ACAD) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227.53% |
| Dec 31, 2025 | -1,979.65% |
| Sep 30, 2025 | -88.10% |
| Jun 30, 2025 | 135.94% |
| Mar 31, 2025 | -161.94% |
| Dec 31, 2024 | 968.39% |
| Sep 30, 2024 | 31.40% |
| Jun 30, 2024 | -271.70% |
| Mar 31, 2024 | -82.22% |
| Dec 31, 2023 | 848.11% |
| Sep 30, 2023 | 93.30% |
| Jun 30, 2023 | -202.59% |
| Mar 31, 2023 | 540.26% |
| Dec 31, 2022 | -366.57% |
| Sep 30, 2022 | 123.05% |
| Jun 30, 2022 | -213.24% |
| Mar 31, 2022 | 8.88% |
| Dec 31, 2021 | 130.64% |
| Sep 30, 2021 | -359.16% |
| Jun 30, 2021 | -74.18% |
| Mar 31, 2021 | 82.94% |
| Dec 31, 2020 | -189.01% |
| Sep 30, 2020 | 3.30% |
| Jun 30, 2020 | 978.41% |
| Mar 31, 2020 | 92.01% |
| Dec 31, 2019 | -162.95% |
| Sep 30, 2019 | 1,445.09% |
| Jun 30, 2019 | 37.91% |
| Mar 31, 2019 | -151.31% |
| Dec 31, 2018 | 805.64% |
| Sep 30, 2018 | 75.43% |
| Jun 30, 2018 | -188.58% |
| Mar 31, 2018 | 209.41% |
| Dec 31, 2017 | -38.58% |
| Sep 30, 2017 | -129.36% |
| Jun 30, 2017 | -121.50% |
| Mar 31, 2017 | -151.40% |
| Dec 31, 2016 | -45.51% |
| Sep 30, 2016 | 150.42% |
| Jun 30, 2016 | -159.45% |
| Mar 31, 2016 | 133.23% |
| Dec 31, 2015 | 239.81% |
| Sep 30, 2015 | -233.50% |
| Jun 30, 2015 | 15.26% |
| Mar 31, 2015 | -42.84% |
| Dec 31, 2014 | 12.40% |
| Sep 30, 2014 | 127.39% |
| Jun 30, 2014 | -197.65% |
| Mar 31, 2014 | 89,308.42% |
| Dec 31, 2013 | 99.24% |
| Sep 30, 2013 | -314.15% |
| Jun 30, 2013 | 114.73% |
| Mar 31, 2013 | -179.11% |
| Dec 31, 2012 | 4,291.76% |
| Sep 30, 2012 | -132.60% |
| Jun 30, 2012 | 374.23% |
| Mar 31, 2012 | 6.66% |
| Dec 31, 2011 | -581.76% |
| Sep 30, 2011 | -75.11% |
| Jun 30, 2011 | 3,815.63% |
| Mar 31, 2011 | 98.86% |
| Dec 31, 2010 | -478.62% |